Beijing – February 28, 2022 – Cooley was recognized as the Healthcare & Life Sciences International Firm of the Year at the 2021 China Law & Practice Awards. Additionally, the firm was listed as a finalist for Investment Funds Firm of the Year and Private Equity & Venture Capital Firm of the Year.
The distinctions complement Cooley’s continued growth in Asia, where the firm advises clients on unique business opportunities and legal challenges across the region.
Cooley represents some of Asia’s most innovative and dynamic life sciences and technology companies, advising on financings, corporate partnering and licensing, M&A, joint venture, capital markets and other strategic transactions. In addition, the firm has helped more than 100 fund managers in Asia form hundreds of venture capital and private equity funds. Cooley has been broadly recognized for its powerhouse technology, life sciences and venture capital practices, and has been named Healthcare & Life Sciences International Firm of the Year and Investment Funds International Firm of the Year by China Law & Practice in past years.
The annual award event identifies and honors the biggest and most important commercial legal matters involving lawyers and parties in China.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe.